News

  1. InvestING In Pharmaceutics And Manufacturing Capabilities 4/5/2024
  2. Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession And Board Changes 3/22/2024

    Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that its Board of Directors unanimously approved the conclusion of its review of strategic alternatives that was initiated in March 2023, and, concurrently therewith, announced several strategic updates related to its operations on a stand-alone basis.

  3. SMC Ltd. Announces Expansion Of Sterile Fill Finish Capabilities, Unveiling State-Of-The-Art Facility In North Carolina 3/13/2024

    SMC Ltd., the worldwide contract manufacturer of single use and disposable medical devices, has today announced the acquisition of an end-to-end fill/finish facility in Charlotte, North Carolina. The facility enables SMC to offer a wider portfolio of services to its pharma clients including lab-to-market development, analytical services, device manufacture, fill/finish, final assembly, and secondary packaging.

  4. SGD Pharma Successfully Trials Hydrogen Burners At Its Saint-Quentin-Lamotte (SQLM) Plant To Accelerate Its Ambitious Decarbonization Roadmap 3/12/2024

    At the end of January, SGD Pharma, a global leader in glass primary packaging for the pharmaceutical industry, started a two-week trial using 100% hydrogen burners for industrial-scale glass production. The trial, conducted at SGD Pharma’s state-of-the-art Saint-Quentin-Lamotte (SQLM) manufacturing plant in France, was a resounding success and will inform SGD Pharma’s decarbonization roadmap which aims to reduce CO2 emissions from 2020 by 35% in 2030 and by 65% in 2040.

  5. Bringing Engineering, Clinical Study Expertise To A New Collaboration 3/8/2024

    Battelle, the world’s largest independent, non-profit R&D company, and Spark Biomedical, Inc., a Dallas-based pioneer in wearable neurostimulation technologies are collaborating on the development of a non-invasive device to tackle the harmful effects of Acute Stress Reactions (ASR).

  6. Aprecia And Battelle Are Impacting The Pharmaceutical Industry Through 3D Printing Innovation 3/8/2024

    Aprecia, a precision drug delivery company, has partnered with the research and development experts at Battelle to develop groundbreaking 3D printing platforms with the potential to transform the way medicines are developed, manufactured, distributed, and administered.

  7. Elizabeth Hickman To Succeed Tim Scott As AustinPx CEO 3/5/2024

    AustinPx, developers of the next generation amorphous dispersion platform, KinetiSol™ Technology, and a contract development and manufacturing organization (CDMO), today announced that Elizabeth Hickman, chief business officer, will succeed Tim Scott in January 2025 as president and CEO of AustinPx. Scott has led the company’s new direction as a CDMO since 2022, successfully positioning the company’s leadership as an oral drug delivery dosage form development CDMO. Scott will stay on as executive chair following the transition and Hickman will be named to the Board of Directors.

  8. Allegheny Performance Plastics® Launches Into Healthcare Sector 3/5/2024

    To meet the growing needs of the healthcare industry, Allegheny Performance Plastics is proud to announce the addition of clean and white room environments, including a dedicated automated work cell to be completed later this year.

  9. Adare Pharma Solutions To Expand Packaging & Warehousing Capabilities In Europe 3/5/2024

    Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced that work has begun to add packaging capabilities and further warehousing capacity at its Pessano facility in Milan, Italy.

  10. SGD Pharma Awarded 2024 Gold EcoVadis Rating In Recognition Of Its Commitment To Sustainability 2/26/2024

    SGD Pharma, a global leader in glass pharmaceutical packaging, has achieved a gold medal in EcoVadis’ 2024 sustainability ratings. Building upon previous years, SGD Pharma’s score of 77 puts the business in the 98th percentile for manufacturers of glass and glass products. EcoVadis, the world’s most trusted provider of sustainability ratings, assesses more than 125,000 companies across four main areas: Environment, Labor and Human Rights, Sustainable Procurement and Ethics.